JP Morgan Healthcare Conference, Day Two: Thermo Fisher Scientific, Affymetrix, Danaher, Hologic, Genmark, Accelerate Diagnostics | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – The 33rd Annual JP Morgan Healthcare Conference continued Tuesday with presentations from Thermo Fisher Scientific, Affymetrix, Danaher, Hologic, Genmark, Accelerate Diagnostics and other life science research and molecular diagnostic firms.

The following are capsules from the above companies. Coverage of Monday's sessions is available here.

Thermo Fisher Scientific

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.